IP Library Granted Patent US 7,627,382
Granted Patent B2
US 7,627,382 · App. 11/137,162 · Granted Dec 1, 2009

Medical devices with aromatic polyimide coating

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,627,382
App. No.
11/137,162
Granted
Dec 1, 2009
Kind
B2
Abstract

Medical devices that include on at least some portion thereof an aromatic polyimide of the structure: wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by benzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R′ is a divalent benzenoid radical selected from the group consisting of wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms, R′″ and R″″ are selected from the group consisting of alkyl and aryl. In one embodiment the medical device is a coated lead body. Coated guide wires are a further embodiment. Methods of application are a further embodiment.

Claims (60)

1. An implantable medical device, comprising:

a lead body extending from a proximal end to a distal end;

a plurality of conductors extending between the proximal end and the distal end of the lead body; and

a single insulative layer positioned about each of the plurality of conductors, wherein the insulative layer is formed of an aromatic polyimide of the following structure:

wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by benzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R″ is a divalent benzenoid radical selected from the group consisting of

wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms,

wherein R′″ and R″″ are selected from the group consisting of alkyl and aryl.

2. The implantable medical device of claim 1 , wherein the insulative layer has a thickness of between approximately 0.0001 inches and approximately 0.0050 inches.

3. The implantable medical device of claim 1 , wherein the insulative layer is positioned about the plurality of conductors in multiple coats to form multiple layers.

4. The implantable medical device of claim 1 , wherein the plurality of conductors form a conductor coil having an outer diameter between approximately 0.010 inches and approximately 0.110 inches.

5. The implantable medical device of claim 1 , wherein one or more of the plurality of conductors form a single circuit.

6. The implantable medical device of claim 1 , further comprising a redundant insulative layer positioned about the plurality of conductors.

7. The implantable medical device of claim 6 , wherein the redundant insulative layer is formed of a material having a flex modulus less than the insulative layer surrounding the plurality of conductors.

8. An implantable medical device, comprising:

a housing generating electrical signals for delivering therapy, the housing having a connector block;

a lead having a lead body extending from a proximal end to a distal end, the proximal end of the lead body being insertable within the connector block and electrically coupling the housing and the lead;

a plurality of conductors extending between the proximal end and the distal end of the lead body;

and an insulative layer positioned about the plurality of conductors, wherein the insulative layer is formed of a aromatic polyimide having the following structure:

wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by benzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R′ is a divalent benzenoid radical selected from the group consisting of

wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms,

wherein R′″ and R″″ are selected from the group consisting of alkyl and aryl.

9. The implantable medical device of claim 8 , wherein the insulative layer has a thickness of between approximately 0.0001 inches and approximately 0.0050 inches.

10. The implantable medical device of claim 8 , wherein the insulative layer is positioned about the plurality of conductors in multiple coats to form multiple layers.

11. The implantable medical device of claim 8 , wherein the plurality of conductors form a conductor coil having an outer diameter between approximately 0.010 inches and approximately 0.1 10 inches.

12. The implantable medical device of claim 8 , wherein one or more of the plurality of conductors forms a single circuit.

13. The implantable medical device of claim 8 , further comprising a redundant insulative layer positioned about the plurality of conductors.

14. A guidewire comprising proximal, medial, and distal segments, the guidewire having coated on some portion of at least one of the segments an aromatic polyimide having the structure:

wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by beuzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R′ is a divalent benzenoid radical selected from the group consisting of

wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms,

wherein R′″ and R″″ are selected from the group consisting of alkyl and aryl.

15. A method for manufacturing a medical device, the method comprising the step of forming on at least some portion of the device a layer of aromatic polyimide of the structure:

wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by benzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R′ is a divalent benzenoid radical selected from the group consisting of

wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms,

wherein R′″ and R″″ are selected from the group consisting of alkyl and aryl.

16. The method of claim 15 , wherein the forming step comprises a dip coating process.

17. The method of claim 15 , wherein the forming step comprises a spray coating process.

18. The method of claim 15 , wherein the forming step comprises an extrusion process.

19. The method of claim 15 , further comprising the step of forming an additional layer of aromatic polyimide on the lead conductor.

20. The method of claim 15 , further comprising the step of forming multiple additional layers of aromatic polyimide on the device.

21. The method of claim 15 , further comprising the step of forming an insulative layer of material over the layer of aromatic polyimide.

22. The method of claim 21 , wherein the insulative layer comprises a fluoropolymer.

23. A method according to claim 15 wherein the device is a medical electrical lead comprising at least one elongate lead conductor.

24. The method of claim 23 , further comprising the step of winding the lead conductor into a coil.

25. The method of claim 24 , wherein the step of winding precedes the step of forming.

26. The method of claim 24 , wherein the step of winding follows the step of forming.

27. The method of claim 24 , further comprising the step of bundling the conductor with a plurality of other lead conductors to form a cable.

28. A medical electrical lead, comprising a conductor including a single insulative layer of aromatic polyimide, the aromatic polyimide having the structure:

wherein R is a tetravalent aromatic radical, preferably containing at least one ring of six carbon atoms, said ring characterized by benzenoid unsaturation, the four carbonyl groups being attached directly to separate carbon atoms in a ring and each pair of carbonyl groups being attached to adjacent carbon atoms in a ring of the R radical; and wherein R′ is a divalent benzenoid radical selected from the group consisting of

wherein R″ is selected from the group consisting of an alkylene chain having 1-3 carbon atoms,

wherein R′″ and R″″ are selected from the group consisting of alkyl and aryl.

29. The lead of claim 28 , wherein the conductor further includes another layer of aromatic polyimide formed thereover.

30. The lead of claim 28 , wherein the conductor further includes multiple additional layers of aromatic polyimide formed thereover.

31. The lead of claim 28 , wherein the conductor further includes a plurality of bundled wire strands extending within the layer of aromatic polyimide.

32. The lead of claim 28 , wherein the conductor is a one of a plurality of bundled wire strands.

33. The lead of claim 28 , wherein the conductor is a one of a plurality of coiled wire filars.

34. The lead of claim 28 , wherein the conductor further includes a layer of fluoropolymer formed over the layer of aromatic polyimide.

35. A medical device including on at least some portion thereof a polyimide of the structure:

wherein “n” has a value in the range of about 50 to 500.

36. An aromatic polyimide according to claim 35 wherein “n” has a value in the range of 75 to 400.

37. An aromatic polyimide according to claim 35 wherein “n” has a value in the range of 100 to about 350.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2022
From: MANUFACTURERS AND TRADERS TRUST COMPANY (AS ADMINISTRATIVE AGENT)
To: SPECTRUM MANUFACTURING, INC.; MEDSOURCE TECHNOLOGIES, NEWTON INC.; UTI HOLDINGS, LLC; NOBLE-MET LLC; MEDSOURCE TRENTON LLC; MEDSOURCE TECHNOLOGIES, LLC; LAKE REGION MEDICAL, INC.; LAKE REGIONAL MANUFACTURING, INC.; MEDSOURCE TECHNOLOGIES PITTSBURGH, INC.
Reel/Frame 058649/0616 →
SECURITY INTEREST Recorded Sep 10, 2021
From: GREATBATCH LTD.; ELECTROCHEM SOLUTIONS, INC.; LAKE REGION MEDICAL, INC.; LAKE REGION MANUFACTURING, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 057468/0056 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: LAKE REGION MEDICAL, INC.; MEDSOURCE TECHNOLOGIES, NEWTON INC.; MEDSOURCE TECHNOLOGIES, LLC; MEDSOURCE TRENTON LLC; THERMAT ACQUISITION, LLC; UTI HOLDINGS, LLC; SPECTRUM MANUFACTURING, INC.; PORTLYN, LLC; NOBLE-MET LLC; MEDSOURCE TECHNOLOGIES PITTSBURGH, INC.; LAKE REGION MANUFACTURING, INC.
Reel/Frame 036991/0839 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2015
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: LAKE REGION MEDICAL, INC.; MEDSOURCE TECHNOLOGIES, NEWTON INC.; MEDSOURCE TECHNOLOGIES, LLC; MEDSOURCE TRENTON LLC; THERMAT ACQUISITION, LLC; UTI HOLDINGS, LLC; SPECTRUM MANUFACTURING, INC.; PORTLYN, LLC; NOBLE-MET LLC; MEDSOURCE TECHNOLOGIES PITTSBURGH, INC.; LAKE REGION MANUFACTURING, INC.
Reel/Frame 036991/0752 →
SECURITY INTEREST Recorded Oct 27, 2015
From: SPECTRUM MANUFACTURING, INC.; MEDSOURCE TECHNOLOGIES, NEWTOWN INC.; UTI HOLDINGS, LLC; NOBLE MET LLC; MEDSOURCE TRENTON LLC; MEDSOURCE TECHNOLOGIES, LLC; LAKE REGION MEDICAL, INC.; LAKE REGION MANUFACTURING, INC.; MEDSOURCE TECHNOLOGIES PITTS BURGH, INC.
To: MANUFACTURERS AND TRADERS TRUST COMPANY
Reel/Frame 036980/0115 →
SECURITY INTEREST Recorded Mar 13, 2014
From: ACCELLENT INC.; MEDSOURCE TECHNOLOGIES, NEWTON INC.; MEDSOURCE TECHNOLOGIES, LLC; MEDSOURCE TRENTON LLC; THERMAT ACQUISITION, LLC; UTI HOLDINGS, LLC; SPECTRUM MANUFACTURING, INC.; PORTLYN, LLC; LAKE REGION MANUFACTURING, INC.; NOBLE-MET LLC; MEDSOURCE TECHNOLOGIES PITTSBURGH, INC.
To: UBS AG, STAMFORD BRANCH, AS THE COLLATERAL AGENT
Reel/Frame 032443/0341 →
SECURITY INTEREST Recorded Mar 13, 2014
From: ACCELLENT INC.; MEDSOURCE TECHNOLOGIES, NEWTON INC.; MEDSOURCE TECHNOLOGIES, LLC; MEDSOURCE TRENTON LLC; THERMAT ACQUISITION, LLC; UTI HOLDINGS, LLC; SPECTRUM MANUFACTURING, INC.; PORTLYN, LLC; LAKE REGION MANUFACTURING, INC.; NOBLE-MET LLC; MEDSOURCE TECHNOLOGIES PITTSBURGH, INC.
To: GOLDMAN SACHS BANK USA
Reel/Frame 032446/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2005
From: MINAR, CHRIS; SENN, ANDREW; WHEALON, WILLIAM; RITTENOUR, BRUCE
To: LAKE REGION MANUFACTURING, INC.
Reel/Frame 016402/0505 →